Genetron Holdings Ltd

Genetron Holdings Ltd (GTH) priced its initial public offering on Jun 22, 2020 at $16.00 per ADS, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $1.41B. Credit Suisse was lead-left underwriter, joined by CICC, BTIG and Canaccord Genuity. Davis Polk and Walkers advised the company and Clifford Chance and Fangda Partners advised the underwriters.

Genetron Holdings Ltd is a Cayman Islands holding company whose PRC businesses operate through a variable interest entity. It runs a precision oncology platform in China specializing in cancer molecular profiling, using molecular biology and data technologies, with a mission to transform cancer treatment and prevention.

Status

IPO

Ticker

GTH

Exchange

Nasdaq Global Market

Priced

Jun 22, 2020

IPO price

$16.00 per ADS

Market cap at IPO price

$1.41B

First filed

Nov 21, 2019

Underwriters

Credit Suisse, CICC, BTIG and Canaccord Genuity

Company counsel

Davis Polk and Walkers

Underwriters' counsel

Clifford Chance and Fangda Partners

Sector

Healthcare

Country / state

China

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.